Novel strategies for relapsed and refractory acute myeloid leukemia.

  title={Novel strategies for relapsed and refractory acute myeloid leukemia.},
  author={Anthony R Mato and Alicia Katherine Morgans and Selina M. Luger},
  journal={Current opinion in hematology},
  volume={15 2},
PURPOSE OF REVIEW Treatment for relapsed or refractory acute myeloid leukemia remains a major challenge for the leukemia community. Although several approaches have been tested in phase II study designs, few comparative data exist to guide treatment choices. We searched the recent literature in Medline, EMBASE and BIOSIS, and abstracts from the American Society of Hematology and American Society of Clinical Oncology published between 2005 and 2007. We reviewed each report to identify studies… CONTINUE READING